Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros

The present work is the result of a comparative study between two routes of ad- ministration for the treatment of transmissible venereal tumor (TVT)., Ten dogs that came to consultation to the Veterinary Teaching Hospital were sampled. For each in- dividual, a clinical sheet was made and samples of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijä: Guerrero Santacruz, Tobias (author)
Aineistotyyppi: bachelorThesis
Kieli:spa
Julkaistu: 2019
Aiheet:
Linkit:http://dspace.unl.edu.ec/jspui/handle/123456789/22195
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
_version_ 1857833169374412800
author Guerrero Santacruz, Tobias
author_facet Guerrero Santacruz, Tobias
author_role author
collection Repositorio Universidad Nacional de Loja
dc.contributor.none.fl_str_mv Pérez González, Galo Fabricio
dc.creator.none.fl_str_mv Guerrero Santacruz, Tobias
dc.date.none.fl_str_mv 2019-07-24T22:26:37Z
2019-07-24T22:26:37Z
2019-07-24
dc.format.none.fl_str_mv 95 p.
application/pdf
dc.identifier.none.fl_str_mv http://dspace.unl.edu.ec/jspui/handle/123456789/22195
dc.language.none.fl_str_mv spa
dc.publisher.none.fl_str_mv Loja
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc-sa/3.0/ec/
info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv reponame:Repositorio Universidad Nacional de Loja
instname:Universidad Nacional de Loja
instacron:UNL
dc.subject.none.fl_str_mv PERRO
SARCOMA
QUIMIOTERAPIA
dc.title.none.fl_str_mv Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/bachelorThesis
description The present work is the result of a comparative study between two routes of ad- ministration for the treatment of transmissible venereal tumor (TVT)., Ten dogs that came to consultation to the Veterinary Teaching Hospital were sampled. For each in- dividual, a clinical sheet was made and samples of the bloody secretion of the tumor were collected, which were then taken to the laboratory for their respective analysis. The systemic effect was compared with two routes of administration of vincristine. In five patients it was put the subcutaneous route (SC) with a dose of 0.025mg / kg of vincristine diluted in 3ml of 0.9 % sodium chloride, every 7 days in the dog’s upper rib cage. Likewise, in 5 individuals it was applied IV administration with the same dose of vincristine described above, prior to the application of a drug protocol to res- tore the patient (0.9 % sodium chloride serum every 7 days) . It was proved that the SC route is viable and offered efficacy in the remission of the tumor in 5 patients. There was no statistical difference in the duration of treatment in the comparison of the two routes (p-value = 0.6265). , The route Ev had an average of 3.6 applications and 32.2 days while; the Sc route an average of 4.2 applications, with 32.6 days. In relation to costs, the Sc route was cheaper than the Ev route, with costs of $ 9.80 (Sc) and $ 21.19 (Ev) for each session; in this study the costs for the 5 patients treated by route Sc was $ 148.40 and Ev $ 404.44.It is concluded that vincristine was effective by SC route for the treatment of TVT with economical benefits and safety in patients, including geriatric and decayed patiens. Key words: Dogs, chemotherapy, sarcoma, neoplasia, TVT, vincristine.
eu_rights_str_mv openAccess
format bachelorThesis
id UNL_b49043f93058c8e07c0b204a6016f4fb
instacron_str UNL
institution UNL
instname_str Universidad Nacional de Loja
language spa
network_acronym_str UNL
network_name_str Repositorio Universidad Nacional de Loja
oai_identifier_str oai:dspace.unl.edu.ec:123456789/22195
publishDate 2019
publisher.none.fl_str_mv Loja
reponame_str Repositorio Universidad Nacional de Loja
repository.mail.fl_str_mv *
repository.name.fl_str_mv Repositorio Universidad Nacional de Loja - Universidad Nacional de Loja
repository_id_str 0
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/3.0/ec/
spelling Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perrosGuerrero Santacruz, TobiasPERROSARCOMAQUIMIOTERAPIAThe present work is the result of a comparative study between two routes of ad- ministration for the treatment of transmissible venereal tumor (TVT)., Ten dogs that came to consultation to the Veterinary Teaching Hospital were sampled. For each in- dividual, a clinical sheet was made and samples of the bloody secretion of the tumor were collected, which were then taken to the laboratory for their respective analysis. The systemic effect was compared with two routes of administration of vincristine. In five patients it was put the subcutaneous route (SC) with a dose of 0.025mg / kg of vincristine diluted in 3ml of 0.9 % sodium chloride, every 7 days in the dog’s upper rib cage. Likewise, in 5 individuals it was applied IV administration with the same dose of vincristine described above, prior to the application of a drug protocol to res- tore the patient (0.9 % sodium chloride serum every 7 days) . It was proved that the SC route is viable and offered efficacy in the remission of the tumor in 5 patients. There was no statistical difference in the duration of treatment in the comparison of the two routes (p-value = 0.6265). , The route Ev had an average of 3.6 applications and 32.2 days while; the Sc route an average of 4.2 applications, with 32.6 days. In relation to costs, the Sc route was cheaper than the Ev route, with costs of $ 9.80 (Sc) and $ 21.19 (Ev) for each session; in this study the costs for the 5 patients treated by route Sc was $ 148.40 and Ev $ 404.44.It is concluded that vincristine was effective by SC route for the treatment of TVT with economical benefits and safety in patients, including geriatric and decayed patiens. Key words: Dogs, chemotherapy, sarcoma, neoplasia, TVT, vincristine.El presente trabajo es el resultado de un estudio comparativo entre dos vías de administración para el tratamiento del tumor venéreo transimisble (TVT), realize el muestreo en 10 caninos que llegaron a consulta al Hospital Docente Veterinario, se realizó una hoja clínica y se recolectó muestras de secreción sanguinolenta del tu- mor, que luego fueron llevadas a laboratorio para su respectivo análisis. Se comparó el efecto sistémico de dos vías de administración de vincristina. En 5 pacientes se colocó vía subcutánea (Sc) con una dosis de 0.025mg/kg de vincristina diluida en 3ml de cloruro de sodio al 0.9 %, cada 7 días en la parrilla costal alta del perro; Así mismo, en 5 individuos se administró la vía endovenosa (Ev) en la cual se uso la misma dosis de vincristina descrita anteriormente, previo a la aplicación de un proto- colo de medicamentos para restaurar al paciente (suero de cloruro de sodio al 0.9 % cada 7 días). Se comprobó que la vía Sc es viable y ofrece un 100 % de eficacia en la remisión del tumor en 5 pacientes. No existió diferencia estadística en la duración del tratamiento en la comparación de las dos vías (p-value = 0.6265). La vía Ev tuvo una media de 3.6 aplicaciones y 32.2 días mientras que, la vía Sc una media de 4.2 aplicaciones, con 32.6 días; Los costos en la vía Sc resultaron más económicos que la vía Ev teniendo valores de un tratamiento para un perro de aproximadamente 10 kg un costo de $9.80 (Sc) y $21,19 (Ev) por sesión de quimioterapia; en esta inves- tigación los costos para los 5 pacientes tratados por vía Sc fueron de $ 148.40 y en la vía Ev $ 404.44. Se concluye que la vía Sc se puede ofrecer como alternativa para el tratamiento de TVT, es económica y segura sobre todo en pacientes decaídos y geriátricos. Palabras claves: Perros, quimioterapia, sarcoma, neoplasia, TVT, vincristina.LojaPérez González, Galo Fabricio2019-07-24T22:26:37Z2019-07-24T22:26:37Z2019-07-24info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesis95 p.application/pdfhttp://dspace.unl.edu.ec/jspui/handle/123456789/22195spahttp://creativecommons.org/licenses/by-nc-sa/3.0/ec/info:eu-repo/semantics/openAccessreponame:Repositorio Universidad Nacional de Lojainstname:Universidad Nacional de Lojainstacron:UNL2025-05-02T17:51:15Zoai:dspace.unl.edu.ec:123456789/22195Institucionalhttps://dspace.unl.edu.ec/Universidad públicahttps://unl.edu.ec/https://dspace.unl.edu.ec/oaiEcuador***opendoar:02025-05-02T17:51:15falseInstitucionalhttps://dspace.unl.edu.ec/Universidad públicahttps://unl.edu.ec/https://dspace.unl.edu.ec/oai*Ecuador***opendoar:02025-05-02T17:51:15Repositorio Universidad Nacional de Loja - Universidad Nacional de Lojafalse
spellingShingle Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
Guerrero Santacruz, Tobias
PERRO
SARCOMA
QUIMIOTERAPIA
status_str publishedVersion
title Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
title_full Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
title_fullStr Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
title_full_unstemmed Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
title_short Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
title_sort Uso de vincristina por vía subcutánea y endovenosa en el tratamiento de tumor venéreo transmisible en perros
topic PERRO
SARCOMA
QUIMIOTERAPIA
url http://dspace.unl.edu.ec/jspui/handle/123456789/22195